O

ONWARD Medical NV
F:63E

Watchlist Manager
ONWARD Medical NV
F:63E
Watchlist
Price: 2.62 EUR 0.19% Market Closed
Market Cap: €90.7m

Wall St Price Targets

63E Price Targets Summary
ONWARD Medical NV

Wall Street analysts forecast 63E stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 63E is 14.1 EUR with a low forecast of 11.85 EUR and a high forecast of 16.73 EUR.

Lowest Forecast
Price Target
11.85 EUR
352% Upside
Average Forecast
Price Target
14.1 EUR
438% Upside
Highest Forecast
Price Target
16.73 EUR
539% Upside
ONWARD Medical NV Competitors:
Price Targets
GNL
Global Net Lease Inc
8% Upside
UNFI
United Natural Foods Inc
-6% Downside

Revenue
Forecast

N/A
Past Growth
153% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss
N/A
Past Growth
153% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 153%.

Gross Profit
Forecast

N/A
Past Growth
135% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
135% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 3 years is 135%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 63E's stock price target?
Price Target
14.1 EUR

According to Wall Street analysts, the average 1-year price target for 63E is 14.1 EUR with a low forecast of 11.85 EUR and a high forecast of 16.73 EUR.

What is the Revenue forecast for ONWARD Medical NV?
Projected CAGR
153%

The compound annual growth rate for Revenue over the next 3 years is 153%.

What is the Gross Profit forecast for ONWARD Medical NV?
Projected CAGR
135%

The compound annual growth rate for Gross Profit over the next 3 years is 135%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett